African American HIV University
Science & Treatment College
2015 – 2016 List of Speakers
OLADUNNI ADEYIGA oadeyiga@mednet.ucla.edu
Oladunni Adeyiga is an Infectious Diseases STAR Fellow in the Division of
Infectious Diseases, Department of Medicine in the David Geffen School of
Medicine at UCLA. As a member of the Specialty Training and Advanced
Research (STAR) program, she is completing research training in the
Department of Bioengineeing at the UCLA Henry Samueli School of
Engineering & Applied Science. She received her B.S. in Chemical Engineering from UMCP in 1999, and her M.D. from the University of Maryland, Baltimore in 2003. She completed residency at the University of Rochester-Strong
Memorial Hospital Internal Medicine Residency Program in 2006, and is ABIM board certified in both Internal Medicine and Infectious Diseases. Her PhD advisor in bioengineering is
Dino Di Carlo, an expert in inertial microfluidics. In the Di Carlo lab, the focus is on exploiting unique physics, microenvironment control, and the potential for automation associated with miniaturized systems for applications in basic biology, medical diagnostics, and cellular engineering. Her current project focuses on looking at ways that we can use inertial microfluidics to rapidly diagnose bloodstream infection. Her long term career goal is to pursue a career in academic medicine geared toward the innovation of new diagnostic tools in the field of clinical infectious diseases so that physicians can make more prompt and accurate diagnoses of illnesses.
She is of Nigerian descent, and grew up in Mitchellville, MD, USA. Her interests include Jesus Christ
(because He’s awesome!) cooking, especially with the year round farmer’s markets in Los Angeles, and community service.
Di Carlo Lab Website http://biomicrofluidics.com/index.php
PAUL ALLYN, MD pallyn@mednet.ucla.edu
JON BAGHDADI, MD jbagdhadi@mednet.ucla.edu

DEBIKA BHATTACHARYA, MD debikab@mednet.ucla.edu
Dr. Bhattacharya joined the UCLA faculty in 2006, and she specializes in the management of HIV and HIV/viral hepatitis co-infection. She graduated from the seven-year accelerated medical program at Boston University, receiving her MD in 1997 and then trained in internal medicine at Baylor University in
Houston, Texas and completed an infectious diseases fellowship at Stanford
University. She has HIV clinics at the CARE Center and an HIV/viral hepatitis co-infection clinic at the West Los Angeles VeteranÆs Affairs Medical Center. Her research involves identifying molecular and clinical predictors of viral hepatitis outcomes in HIV co-infection, as well as studies evaluating the predictors of clinical outcomes in HIV/HBV co-infected patients in South Africa and mother-to-child transmission of HBV in HIV/HBV co-infected pregnant women.
DERRICK BUTLER MD, MPH
DButler@tohelpeveryone.org
Dr. Butler is a Family Medicine Physician and HIV Specialist practicing in South
Central Los Angeles. He received his undergraduate degree from Morehouse
College in Atlanta, GA and his medical degree from the University of California,
San Francisco. He currently serves as Associate Medical Director at the T.H.E.
Clinic, a long standing federally qualified community health center and is the director of T.H.E Clinic’s HIV Program. He also serves as Assistant Professor with the Pacific AIDS Education and Training Center at Charles Drew University. Dr.
Butler is focused on addressing the current HIV/AIDS epidemic and the health disparities of urban populations. With an additional interest in international health, Dr. Butler has also lived in Africa as a Peace Corps Volunteer and participated in medical missions in various parts of Africa.
JESSE CLARK, MD, MSc jlclark@mednet.ucla.edu
Dr. Clark is Assistant Professor-in-Residence in the Department of Medicine, Division of Infectious Diseases and Director of Latin American Programs, UCLA Program in
Global Health (PGH). Dr. Clark is based in Lima, Peru where he conducts research on
HIV and STI prevention in Latin America. He has studied patterns of HIV and STI transmission among men who have sex with men (MSM) populations in urban Peru as well as techniques for the improved detection of HIV and other STIs in resourcelimited settings. He is currently conducting studies of partner-based strategies for HIV and STI control among MSM in Peru. His research interests include partner notification, partner treatment, and epidemiology of HIV/STI’s in Latin America.
THOMAS J. COATES, PHD tcoates@mednet.ucla.edu

Dr. Coates is the Michael and Sue Steinberg Endowed Professor of Global AIDS Research within the
Division of Infectious Diseases at UCLA. He is the Director of the UCLA Center for World Health – a collaborative initiative of the David Geffen School of Medicine and the UCLA Health System. He also leads the Program in Global Health at UCLA. He co-founded the Center for AIDS Prevention Studies
(CAPS) at UCSF in 1986 and directed it from 1991 to 2003. He was the founding Executive Director of the
UCSF AIDS Research Institute, leading it from 1996 to 2003. His areas of emphasis and expertise are HIV prevention, the relationship of prevention and treatment for HIV, and HIV policies. He directs the
Behavioral Core of the NIH funded HIV Prevention Trials Network, and is conducting policy research domestically and internationally. He was elected to the Institute of Medicine in 2000.
RANIYAH COPELAND, MPH raniyahc@blackaids.org
As the Director of Training & Capacity Building at the Black AIDS Institute (the
Institute), Raniyah is the organization’s chief HIV prevention expert and manage all HIV treatment/prevention and community mobilization training and internship programs through the African American HIV University (AAHU). Under the AAHU program Raniyah manages the Science and Treatment College, Community
Mobilization College the Black Treatment Advocates Network and all other
Institute training programs.
Also experienced in direct-services, Raniyah has worked at Planned Parenthood as a Health Educator promoting healthy and responsible sexual choices, conducting HIV and STI testing as well as coordinating policy research, legislative tracking and policy watch-dogging. Raniyah also provided comprehensive case management and transitional support to homeless clients while coordinating temporary placements of clients outside of the Skid Row area as a Crisis Case Manager with another
NPO. Deeply committed to the Black Community, Raniyah also served as the Executive Director of the
Black Recruitment and Retention Center managing the joint effort between students and the University of California, Berkeley to increase and retain Black students in the UC System.
Raniyah has presented in numerous settings on topics related to HIV issues such as mobilization theory, epidemiology, policy, and successful health program development and delivery.
Mrs. Copeland attended the University of California, Berkeley studying the field of Public Health and
African American Studies and has a Masters in Urban Public Health from Charles Drew University of
Medicine and Science in Los Angeles.
WILLIAM CUNNINGHAM, MD, MPH wcunningham@mednet.ucla.edu
Dr. Cunningham is a Professor in the Division of General Internal Medicine,
Department of Medicine, School of Medicine and in the Department of Health
Services, School of Public Health, UCLA. He received his training in health services research through the Robert Wood Johnson Clinical Scholars Program,

and received his MPH degree in epidemiology from UCLA in 1993. In 2004 he was elected into the prestigious American Society for Clinical Investigation (ASCI).
He is PI of a NIDA-funded R-01 study to conduct a peer navigation intervention designed to link and retain HIV+ inmates in HIV care upon release from the Los Angeles County jails system (LINK LA). He is also PI of an R34 grant in which he is developing and culturally adapting an intervention to improve retention in care among Latinos living with HIV. Recent research roles have included being PI of an
NIMH-funded R01 on HIV vaccines acceptability, HIV prevention, and disparities (LA VOICES) and a Ryan
White Program Special Project of National Significance (SPNS) evaluating a peer navigation outreach intervention study for hard-to-reach HIV+ persons. He is currently lead evaluator on another Ryan White
Program SPNS project evaluating the impact of a health information technology (IT) intervention on quality of HIV care.
He was PI of the UCLA component of HCSUS – the first study of a nationally representative sample of
HIV+ persons receiving medical care in the US, and led one of the three Research Teams for the project from 1996-2002, publishing numerous papers, many of which are relevant to the current project. He has conducted a number of studies that enrolled and followed vulnerable, diverse, poor, hard-to-reach HIV+ populations. He has authored more than 110 peer-reviewed scientific articles, many of which address engagement and retention in HIV care, barriers to care, use of services, racial disparities, HIV prevention, and health outcomes for vulnerable persons living with HIV. His responsibilities also include
Co-director of the Investigator Development Core for the NIA-funded Resource Centers for Minority
Aging Research (RCMAR), serving as Director of the Training Core for the NCMHD-funded project Export, and Associate Director of the Robert Wood Johnson Clinical Scholars Program at UCLA. He is also Co-
Director of the UCLA CTSI Education Core TL1, and teaches courses on health services organization, and outcomes and effectiveness research.
He is an established investigator in the area of health care and health outcomes in HIV, with a focus on minority and other vulnerable populations. Recent research roles have included being PI of an NIMHfunded R-01 on HIV vaccines acceptability, HIV prevention, and disparities (LA VOICES) and a Ryan White
Program Special Project of National Significance (SPNS) evaluating a peer navigation outreach intervention study for hard-to-reach HIV+ persons. He is currently lead evaluator on another Ryan
White Program SPNS project evaluating the impact of a health information technology (IT) intervention on quality of HIV care.
ERIC DAAR, MD edaar@labiomed.org
Dr. Daar received his undergraduate degree from UCLA and medical degree from
Georgetown University School of Medicine. He completed an internship and residency in internal medicine at Cedars-Sinai Medical Center and his clinical and research fellowship in infectious diseases at Cedars-Sinai Medical Center and
UCLA. Dr. Daar is currently the chief of the Division of HIV Medicine at Harbor-
UCLA Medical Center and professor of medicine at the David Geffen School of
Medicine at UCLA. He is a member of numerous scientific societies, the recipient of many grants, and author of more than 300 original manuscripts and abstracts. He has been a reviewer for many scientific and clinical journals and is a member of the editorial board of Current HIV/AIDS reports, AIDS, AIDS Research and Treatment and the editorial advisory board of the Journal of Infectious
Diseases. He also chairs the NIAID Prevention Trials Data Safety Monitoring Board and is a panel

member on the Department of Health and Human Services Guidelines Panel for Antiretroviral Therapy for Adults and Adolescents.
DVORA DAVEY, MPH dvoradavey@ucla.edu
Dvora Joseph Davey is a PhD Candidate in Epidemiology at UCLA Fielding School of Public Health, where she is focusing on infectious disease and behavioral epidemiology. Dvora came to UCLA with over fifteen years experience in international health program development and management, including extensive experience in the design and evaluation of STI/HIV, and reproductive health programs and studies. Dvora has managed complex donor-funded programs and research, including studies of the effectiveness of innovative technologies, service delivery, and community/clinical interventions in Southern
Africa. Dvora's research interests are in the intersection between HIV and reproductive health, and how best to provide women and couples living with HIV safer fertility options.
Dvora received her Master’s in Public Health from Columbia University with a focus on Population and
Family Health.
HOMERO DEL PINO, PHD homerodelpino@cdrewu.edu
Dr. del Pino received his BA from Cornell University and holds a PhD in
Philosophy from UCLA. He has worked in HIV prevention at the national level and with the Centers for Disease Control and Prevention (CDC) as a Master
Trainer for Safety Counts, an evidence-based intervention for active substance users. He’s also been trained in other evidence-based behavioral interventions.
He is currently the Co-Director of both Community Engagement and Innovations and Partnerships for AXIS at Charles R. Drew University. He is interested in aging, HIV, and alcohol/substance use in people of color. His current study explores how social support and family dynamics help or hinder middle-aged (50-64 years old), African-
American, Latino, and White gay men’s efforts to recover from alcohol dependence. He is also interested ethics and bioethics.
HY DOYLE, EdD
LDoyle@mednet.ucla.edu
In addition to his duties as executive director of the UCLA PRIME program, Dr.
Doyle is the principle investigator for the UCLA Summer Medical and Dental

Program, a Robert Wood Johnson funded summer enrichment program. He also serves as co-principle investigator for the UCLA/Drew Post-Baccalaureate Program
Dr. Doyle previously served as the director of the UCLA Center of Excellence and the assistant dean of
Admission, Charles R. Drew University. His areas of interest are formative evaluations of healthcare profession pipeline program, implementation of multiple-mini interviews for medical school admissions, and designing pipeline programs that develop leaders in healthcare for the medically underserved.
KATHIE FERBAS kferbas@mednet.ucla.edu
Dr. Kathie Grovit Ferbas completed her post doctoral fellowship in the laboratory of Dr. Irvin Chen and joined the faculty in the Department of
Medicine in 2000 where she conducted research focused on HIV vaccine development. In 2013, Dr. Ferbas stepped down from UCLA to pursue a teaching position as well as a nutrigenomics and immunology research program at Pepperdine University. Dr. Ferbas rejoined the UCLA AIDS
Institute part time as the CFAR/AI Scientific administrator in June of this year. She can be reached by email at KFerbas@mednet.ucla.edu
ZORAN GALIC, PhD zgalic@ucla.edu
OMAI GARNER, PhD ogarner@mednet.ucla.edu
Dr. Omai Garner is a Health Sciences Assistant Clinical Professor and Associate
Director of Clinical Microbiology in the UCLA Health System. He received his PhD from UC San Diego in Biomedical Sciences. He was a Postdoctoral Clinical
Microbiology CPEP Fellow in the Department of Pathology at UCLA, and a former
McNair Scholar. Dr. Garner is Board Certified by the American Board of Medical
Microbiology. Dr. Garner's research focuses on novel Point of Care Devices for infectious disease diagnosis in the developing world.
Dr. Garner was always taught that science, at its best, is a collaborative process. "It is collaboration, and not competition, which produces the most significant advances in biomedical research."
He also serves as the Chairman of the Board for the Social Justice Learning Institute of Inglewood,
California.
GERALD GARTH
GeraldG@BlackAids.org

Gerald Garth, Program Specialist, at the Black AIDS Institute, works with the organization’s media and communications, including its national newsletter, digital, web, and print contributions, as well as design components for the Institute. He also works with Black Treatment Advocates Network (BTAN) nationally, facilitating and executing trainings, events, and so forth. A 2014 Fellow himself, Gerald is leading the
Institute’s 2015 African-American HIV University cohort.
DAVID GERE, PhD dgere@ucla.edu
David Gere, PhD, is professor of arts activism in the UCLA Department of
World Arts and Cultures/Dance and director of the UCLA Art & Global Health
Center. With photographer Gideon Mendel, he co-directs Through Positive
Eyes, a participatory photo project with people living with HIV and AIDS in ten cities around the world. Through Positive Eyes will debut as an exhibition at the 2016 International AIDS Conference in Durban, South Africa.
MONICA GANDHI, MD
Monica.Gandhi@ucsf.edu
Dr. Monica Gandhi is an expert in infectious diseases, particularly in the care of patients with HIV and AIDS. In her research, she has a special interest in HIV in women, including differences between women and men in antiretroviral exposure and responses to therapy. Her work on these subjects has been widely published.
Gandhi earned a medical degree at Harvard Medical School. At UCSF, she completed an internal medicine residency, infectious diseases fellowship and postdoctoral fellowship at the Center for AIDS Prevention. During her infectious diseases fellowship, she earned a master's degree of public health in epidemiology and biostatistics at the University of California at Berkeley. An assistant professor of medicine, Gandhi has received many awards, including the
Building Interdisciplinary Research Careers in Women's Health Award and the Hellman Award for Early
Career Faculty.
TED GIDEONSE, PhD gideonse@ucla.edu
Ted Gideonse is a Postdoctoral Fellow in the Program in Global Health’s Training
Program in Global HIV/AIDS Prevention Research. Dr. Gideonse has a PhD in

Anthropology from UC San Diego, a BA in Social Anthropology from Harvard, and an MFA in Creative
Writing from the New School University. For his PhD fieldwork, he examined how cultural discourses of health and addiction affected the lives and experiences of meth-using HIV+ MSM in San Diego. Between undergraduate and graduate work, he worked in publishing as a journalist, editor, and finally as as literary agent.
A medical and psychological anthropologist, he is interested in how political structures and moral ideologies impact both mental and physical health, particularly among addicts, the homeless, and people with chronic illnesses like HIV. Dr. Gideonse was awarded funding by UCLA’s Center for HIV
Identification, Prevention, and Treatment Services (CHIPTS) for a pilot study on the risk behaviors of drug offending HIV+ men who have sex with men who were inmates in Los Angeles County Jail. He is also preparing studies focusing on cultural barriers to the use of Pre-Exposure Prophylaxis (PrEP) among high-risk MSM and the role physical and virtual gay venues have in substance abuse among MSM.
PAMINA GORBACH, DrPH, MHS pgorbach@ucla.edu
Pamina M. Gorbach, MHS, DrPH, is a behavioral epidemiologist whose research focuses on the behaviors involved in transmission and acquisition of sexually transmitted infections including HIV especially around substance use. Methodological expertise includes measurement at the sexual partnership level, and adherence and acceptability measures for new methods of HIV prevention including microbicides and pre-exposure prophylaxis and application of technologies for collecting behavioral data. She is a Professor at the University of California, Los
Angeles in the Department of Epidemiology, Fielding School of Public Health and in the Division of
Infectious Diseases, David Geffen School of Medicine. Dr. Gorbach serves as an investigator in the
Adolescent Trials Network (ATN), the HIV Prevention Trials Network (HPTN), the MACS Behavioral
Working Group, and Microbicides Trial Network (MTN). She is the PI with Dr. Steven Shoptaw as Co-PI of a large NIDA funded cohort in Los Angeles entitled “Minority MSM and Substance Cohort at UCLA
Linking Infections Noting Effects” known as “M Study”. Dr. Gorbach heads a Fogarty supported training program for Cambodia entitled “UCLA/Cambodia HIV/AIDS Training Program in Data Management &
Analysis” and has had ongoing research there for 18 years. Local research focuses on HIV and also involves two studies of HPV among MSM. Her global health experience includes Cambodia, Vietnam,
Peru, Costa Rica, the Dominican Republic, Brazil, Mali, Malawi, South Africa, and Ghana.
NINA HARAWA, PhD nharawa@mednet.ucla.edu
Dr. Nina Harawa is an Adjunct Associate Professor with the UCLA Geffen Schools of Medicine and Public Health and an Associate Professor Charles R. Drew
University of Medicine and Science. Trained in Epidemiology, her research

involves understanding trends in HIV and other sexually transmitted infections and developing effective, culturally relevant interventions. She has conducted innovative research in a variety of populations – including high-risk African American men, sexually active African American and Latina women, older adults, and incarcerated and post-incarcerated men and women. Much of this work has involved partnering with local governmental and community organizations. In an effort to foster methodologically sound and effective approaches to addressing health disparities, Dr. Harawa has also written about conceptual issues in the categorization and analysis of racial and ethnic groups in health research. She regularly shares her knowledge and findings by presenting data to community, policy, and academic groups and is co-Director of the Resource Centers for Minority Aging Research, National
Coordinating Center at UCLA. Dr. Harawa has received a number of awards for her community-based research and HIV education efforts, including an Unsung Hero Award from the NAACP in 2011.
REBEKAH ISRAEL, MS rebekahi@blackaids.org
Ms. Israel graduated from UNC Chapel Hill with degrees in Sociology and
Political Science in 2011. In May 2013, Rebekah received a master’s in Sociology at American University (AU) in Washington, DC.
While at AU, she worked on two research grants that addressed the social determinants of HIV risk. The first dealt with HIV risk of re-entrants of the criminal justice system. And the second focused on Black and African-born women and their perceptions of HIV and HIV testing. These appointments piqued her interest and passions in disparities in HIV that led her to the
Black AIDS Institute.
As the Training and Evaluation Coordinator at the Institute, Rebekah works mostly on the local black
Treatment Advocates Network (BTAN) which strengthens local Black leadership and raises HIV science literacy in Black communities nationwide. She is also the lead evaluator for the Institute’s programming.
THEODOROS KELESIDIS, MD tkelesidis@mednet.ucla.edu
Dr. Kelesidis is an Assistant Researcher and Clinical Instructor in the UCLA
Department of Medicine, Division of Infectious Diseases, as well as an
Attending Physician in Infectious Diseases at Ronald Reagan UCLA Medical
Center. He received his MD from Athens University Medical School and completed his residency in Internal Medicine at St. Elizabeth’s Medical
Center in Boston, MA. He is also currently pursuing a PhD in Immunology. His basic research efforts focus on molecular biology studies to elucidate the role of oxidized lipids and lipoproteins in HIV immunopathogenesis, HIV-associated activation of the immune system, and cardiovascular disease. His long-term vision is to define the mechanistic links between HIV infection, immune activation, and
Cardiovascular disease.
ADEN KING

AdenKing@mednet.ucla.edu
SCOTT G. KITCHEN, PhD skitchen@ucla.edu
Dr. Kitchen is an Assistant Professor in the UCLA Department of Medicine,
Division of Hematology/Oncology. He is also the Director of the UCLA
Mouse/Human Chimera Core Laboratory and a member of the JCCC Tumor
Immunology Program Area. Dr. Kitchen’s research interests are focused on investigating the effects of viral infection, as well as other cellular abnormalities, on human hematopoiesis and on exploring ways to correct defects that exist in immunity to viral and cellular antigens. The human immune system is normally fastidious in controlling the environmental assaults that the body receives every day. However, there are many instances where the immune response is ineffective in clearing infection or cancerous cells.
Kitchen’s laboratory is interested in understanding the mechanisms that limit the immune systems’ ability to clear infection or cancer and in developing ways that augment these responses. Specifically, they are investigating the role of the CD4 molecule in multilineage hematopoiesis and in cellular responses, particularly in the context of HIV infection. They are also interested in developing gene therapy-based approaches to engineer human hematopoietic stem cells to reconstitute and/or enhance immune responses following their development into mature cells that specifically target HIV infection as well as other viral and cellular antigens. In addition, his laboratory is interested in the development of mouse/human chimeric models that allow the characterization of human hematopoiesis and engineered immunity in a surrogate in vivo host.
JEFFREY KLAUSNER, MD, MPH jdklausner@mednet.ucla.edu
Dr. Klausner is a Professor of Medicine in the Division of Infectious Diseases and the Program in Global Health. Dr. Klausner earned his Medical Degree from
Cornell University Medical College with Honors in Research. He completed his
Residency in Internal Medicine at the New York University—Bellevue Hospital
Center. Dr. Klausner earned his Master’s in Public Health with a focus on
International Health and Epidemiology at the Harvard School of Public Health.
After that training, Dr. Klausner was an Epidemic Intelligence Service Officer at the
Centers for Disease Prevention and Control. Dr. Klausner completed his Fellowship in Infectious Diseases at the University of Washington, Seattle, under the mentorship of Prof. King Holmes.
From 1998-2009 Dr. Klausner was a Deputy Health Officer, Director of STD Prevention and Control
Services at the San Francisco Department of Public Health, member of the UCSF School of Medicine faculty in the Divisions of AIDS and Infectious Diseases and Attending Physician at San Francisco General
Hospital. While in San Francisco Dr. Klausner helped identify key factors associated with the increase d spread of HIV and STDs and implemented multiple novel public health prevention programs. He helped create the St. James Infirmary, the first occupational health and safety clinic for sex workers and
Magnet, a community-based peer-run sexual health clinic for gay men. From 2009-2011 Dr. Klausner

was Branch Chief for HIV and TB at the Centers for Disease Control in Pretoria, South Africa, helping lead the South African PEPFAR program for care and treatment.
Dr. Klausner’s research interests are in applied epidemiology and the prevention and control of infectious disease s of public health importance like HIV, STDs, TB and cryptococcus. Dr. Klausner has a particular interest in the use of technology—information, digital, and laboratory—to facilitate access to treatment for disadvantaged populations. Dr. Klausner has been funded by the NIH, CDC, private pharmaceutical and test manufacturers to study the benefits of new ways to find and treat infectious diseases. Dr. Klausner has been a leading advocate in the use of medical male circumcision for HIV and
STD prevention. Dr. Klausner is a frequent advisor to the CDC, NIH and WHO and a popular public speaker. Dr. Klausner is a highly sought after mentor who has trained dozens of fellows, residents and students of medicine and public health.
KATRINA KUBICEK, PhD
KKubicek@chla.usc.edu
JORDAN LAKE, MD, MSC jlake@mednet.ucla.edu
Dr. Lake is Assistant Professor in the UCLA Department of Medicine, Division of
Infectious Diseases. Her research focuses on the treatment of metabolic and aging-related complications of HIV and antiretroviral therapy. Additional areas of interest include the specific needs of HIV-infected women, immigrants, and commercial sex workers. Dr. Lake cares for HIV-infected patients at both the CARE
Center and the Valley Community Clinic, where she serves as HIV Medical
Director. She completed her Infectious Disease Fellowship at UCLA in 2009. Prior to that, she completed both Internal Medicine residency and medical school at Baylor
College of Medicine in Houston, Texas.
RAPHAEL J. LANDOVITZ, MD, MSC rlandovitz@mednet.ucla.edu
Dr. Landovitz graduated from Princeton University in 1992 and received his M.D. from Harvard Medical School in 2996. He trained at Brigham and Women’s
Hospital in Boston, Massachusetts in Internal Medicine, and completed subspecialty training in Infectious Diseases and HIV at the Brigham and Women’s
Hospital and Massachusetts General Hospital. Dr. Landovitz additionally served as
Chief Resident at Brigham and Women’s Hospital, and stayed on staff in the Division of Infectious Diseases as an Infectious Disease and HIV care provider and clinical researcher. He also served as Medical Co-Director of the Vietnam-CDC-Harvard Medical School-AIDS-Partnership (VCHAP), helping to train Vietnamese physicians in HIV care and treatment. Dr. Landovitz relocated to Los Angeles in 2006, and is Currently Assistant Professor of Infectious Diseases at UCLA. He has led combination prevention intervention studies and projects using Post-exposure (PEP) and Pre-exposure (PrEP) strategies for MSM, as well as being part of the DAIDS-funded AIDS Clinical Trials Group (ACTG) and HIV

Prevention Trials Network (HPTN). He was awarded the John Carey Young Investigator Award by the
ACTG in 2010.
MARK MALEK, MD, MPH mmalek@ucla.edu
Dr. Mark Malek MD, MPH, is a board-certified Preventive Medicine physician employed in private practice in Long Beach, CA and specializes in Primary Care and Medical Wellness. He completed medical school at UCLA, internship at
Stanford Hospital and Preventive Medicine Residency at the Johns Hopkins
Hospital. He then served as a Lieutenant Commander in the US Public Health
Service at the US Centers for Disease Control in Atlanta, Georgia for two years, followed by seven years’ employment with the Los Angeles County Sheriff’s Department as Director of
Infection Control and Preventive Medicine. Dr. Malek holds an Assistant Adjunct Professor appointment at the UCLA Fielding School of Public Health (FSPH) where he conducts medical and public health research and teaches/mentors graduate students. He has published scholarly manuscripts in multiple peer-reviewed medical journals and delivered presentations at scientific conferences around the world.
MATTHEW MARSDEN, PHD mmarsden@ucla.edu
Dr. Marsden is an Assistant Professor in the Department of Medicine at
UCLA, who has worked in HIV research for over 15 years. He obtained his undergraduate degree and Ph.D. from the University of Edinburgh in
Scotland, UK, and subsequently moved to UCLA to continue work in the fields of HIV molecular biology and pathogenesis. His current research is focused on developing methods for eliminating the HIV reservoirs that persist during antiretroviral therapy. This primarily involves investigating the biology of latently infected CD4+ T cells and chronically infected macrophages, and exploring new approaches to deplete the virus that is harbored by these cells.
RONALD MITSUYASU, MD rmitsuya@mednet.ucla.edu
Dr. Mitsuyasu is Professor of Medicine in the Division of Hematology-Oncology at the Geffen School of Medicine at UCLA and Director of the UCLA Center for
Clinical AIDS Research and Education (CARE Center). He has been a clinical investigator in AIDS and HIV since 1981, conducted many trials with immunebased therapies for HIV, with new treatment strategies for AIDS malignancies and, more recently with gene therapy for HIV, including the first randomized, doubleblind clinical trials of gene therapy in stem cells for HIV. He has served in leadership

positions within the US national HIV clinical trials groups, i.e. AIDS Clinical Trials Group (ACTG), and he is the current Group Chairman of the AIDS Malignancy Consortium (AMC). He serves as the Associate
Director of the UCLA Center for AIDS Research (CFAR) responsible for clinical and translational research in HIV treatment and biomedical prevention at UCLA. He maintains an active outpatient HIV and cancer clinic at UCLA and cares for HIV patients with and without cancers.
ARDIS MOE, MD amoe@mednet.ucla.edu
Dr. Moe began her Infectious Diseases fellowship at UCLA and continued as an
NIH-sponsored HIV Clinical Trials fellow, and then stayed on at UCLA as faculty in the Division of Infectious Diseases. She maintains a clinical practice at the
CARE Center and also at a Ryan White-funded HIV clinic in Van Nuys:
Northeast Valley Health Corporation. She has research interests in HIV dementia and complications of HIV and HIV treatments.
MARIO J. PEREZ, MPH
Assistant: Rochessa Washington, rowashington@ph.lacounty.gov
As Director of DHSP, Mario is responsible for guiding the work of more than 320 employees and managing the annual investment of more than $105 million in local,
State and federal resources that support the delivery of HIV and STD services through nearly 80 Los Angeles County organizations. He is a leader on State, local, and national HIV policy issues, serving as a member of the Presidential Advisory Council on HIV and AIDS, the Board of Directors of the National Minority AIDS Council, a member of the National Council of STD Directors, a new member of the AIDS United Public Policy
Committee and a member of the Los Angeles County Commission on HIV. Mr. Pérez began providing
HIV education and awareness services in 1990 while a student at Berkeley. Over the last 20 years, he has testified before Congress, the Los Angeles County Board of Supervisors, and the Los Angeles City
Council to address a range of HIV/AIDS issues, including the need for scientifically-proven interventions and adequate resources. Mr. Pérez has received recognition for his leadership in the fight against
HIV/AIDS by then Assemblyman Villaraigosa, State Senator Hilda Solis, the Los Angeles City Council, Los
Angeles County Supervisor Mark Ridley-Thomas, and more than a dozen local organizations. He was born, raised and lives in Los Angeles. He earned a Bachelor’s Degree in Biology from UC Berkeley and a
Master of Public Health degree from UCLA.
HYMAN M. SCOTT, MD, MPH hyman.scott@ucsf.edu
Dr. Scott is board certified in internal medicine and infectious diseases, and currently provides care for patients living with HIV at 360: Positive Care Center at UCSF. After receiving his MD from Yale School of Medicine, he completed his
Internal Medicine residency and chief residency at UCSF where he is also a postdoctoral research fellow at the Center for AIDS Prevention Studies. Dr. Scott’s current research interests are in HIV-related disparities among men who have sex with men (MSM) in the U.S. with a focus on development and implementation of novel HIV prevention

strategies to address these disparities. He has led local analyses of disparities in sexual transmitted infections and utilization of HIV prevention services among MSM in San Francisco, CA. He is also using several large longitudinal studies to evaluate age and racial/ethnic disparities in new HIV infections by type of sexual contact among MSM in the U.S. Finally, he is evaluating a novel online HIV prevention tool, and developing an intervention to support home HIV self-testing and linkage to HIV prevention and care services among young Black and Latino MSM in San Francisco and Oakland.
SANGHYUK SHIN, PhD sanghyushin@mednet.ucla.edu
Dr. Sanghyuk Shin is an infectious disease epidemiologist with research interests in TB/HIV co-infection, molecular epidemiology, and global health.
His educational background includes a PhD in Public Health (Global Health track) from the Joint Doctoral Program at San Diego State
University/University California San Diego and a Master of Science in
Epidemiology at the Harvard School of Public Health. He also completed a
Postdoctoral Fellowship in Global HIV/AIDS Prevention Research at UCLA David Geffen School of
Medicine. Dr. Shin has conducted epidemiological research in China, Mexico, Somalia, and Botswana. He also worked on infectious disease surveillance projects at the New York City Office of AIDS Surveillance and California Emerging Infections Program. Dr. Shin is currently the Principal Investigator for NIHfunded research studies on molecular epidemiology of tuberculosis in Botswana. He also works closely with the Los Angeles County Tuberculosis Control Program on TB prevention projects for communities at high risk for TB in Los Angeles County.
STEVE SHOPTAW
SShoptaw@mednet.ucla.edu
Dr. Steven Shoptaw is a licensed psychologist and Director of the Center for
Behavioral and Addiction Medicine at UCLA. He is Professor in the UCLA
Departments of Family Medicine and Psychiatry and Biobehavioral Sciences and
Vice Chair of Research in Family Medicine. Dr. Shoptaw has a portfolio of work that focuses on the treatment of addiction and HIV prevention in the context of addiction in the Western U.S. where stimulant use is the single strongest predictor of HIV transmission. For over 20 years, he has conducted Phase Ib and IIa randomized clinical trials of medications and behavioral interventions for stimulant dependent individuals. Recently he completed a Phase Ib interaction safety study of ibudilast at relevant doses of methamphetamine and is Co-Investigator on a Phase IIa randomized controlled trial of ibudilast as an outpatient treatment for methamphetamine dependence, 50% of whom are HIV-positive. Dr. Shoptaw is a member of the DAIDS-funded, HIV Prevention Trials Network (HPTN) Executive Committee, and site
Principal Investigator for HPTN-073, a feasibility study of Pre-Exposure Prophylaxis (Truvada) in Black men who have sex with men, a group with 7% incidence in Los Angeles and high rates of stimulant and alcohol use. In late 2013, Dr. Shoptaw was awarded a 5-year cooperative agreement (U01 DA036267) to establish a cohort of minority men who have sex with men to investigate interactions between noninjection use of methamphetamine, cocaine, opiates and binge drinking and transmission and progression of HIV.

DONG SUNG AN, MD, PHD dan@sonnet.ucla.edu
Dr. Sung An is an Associate Professor in the Sonnet School of Nursing. He received his MD from Yamaguchi University School of Medicine and his PhD from Tokyo
Medical and Dental University. His research interests include developing hematopoietic stem cell based gene therapy strategies for treating HIV infected patients. His research team investigates efficient introduction of protective genes against HIV into target cells and offer protection against HIV. His research aims to bring basic science findings to the clinic.
CHRIS TYMCHUK, MD, PHD tymchuk@mednet.ucla.edu
CORY WOODYATT cwoodya@emory.edu
Cory Woodyatt is a Senior Research Project Coordinator for AIDSVu.org and
HIVContinuum.org, held within the Rollins School of Public Health at Emory
University, where he is responsible for the day-to-day management of the two projects. Prior to joining the AIDSVu team, Cory worked in the Department of Global
Health conducting research on intimate partner violence (IPV) among gay, bisexual, and other MSM, focusing on how the impact of IPV can affect one’s risk for HIV.
Before moving to Atlanta, Cory served as a Research Analyst at the Public Health
Agency of Canada working in sexual health promotion and HIV/STI prevention while consecutively finishing his education at the University of Ottawa in the Bachelor of Science in Nursing program. Cory also holds a Bachelor of Arts in English and French from Carleton University.
SEAN YOUNG, PhD sdyoung@mednet.ucla.edu

I am an Assistant Professor in the Department of Family Medicine and the executive Director of the
University of California Institute for Prediction Technology. The UC Institute for Prediction Technology bridges researchers across UC campuses to study how data from social technologies can be used to predict real-world events and behaviors. My research is focused on use of social media and mobile health technologies for global HIV and drug use prevention and treatment. I have spent the past decade studying the use of social media to address issues related to HIV and drug use prevention and treatment behavior in the U.S., Peru, and South Africa, among Los Angeles homeless youth, African American and
Latino MSM, Peruvian MSM, and American and Iranian college undergraduates. I was the Primary
Investigator of the Harnessing Online Peer Education (HOPE) UCLA, HOPE Peru, and HOPE Care studies, showing the feasibility of using social media to increase HIV testing and HIV care. Results suggest that the HOPE social media intervention increased requests for HIV testing in the United States and Peru. We recently completed the first study to create methods of using observational big data (> 550 million tweets) from social media for drug and HIV-related surveillance. I was the Conference Chair for the
CHIPTS-sponsored Conference on Technologies for HIV Prevention at UCLA and teach a class for UCLA students in the Spring on building low-cost technologies to address global health issues.
ANJIE ZHEN, PHD anjiezhen@gmail.com
Dr. Zhen is currently a postdoctoral fellow in Dr. Scott Kitchen’s Laboratory at
Department of Medicine – Hematology / Oncology, UCLA. She had obtained her
PhD at Johns Hopkins School of Public Health where she studied innate anti-HIV factor APOBEC3 proteins and their interaction with HIV Vif with Dr. Xiao-fang
Yu. Currently she is investigating novel functions of HIV Vif proteins in association with host transcription factor RUNX proteins and studying immune exhaustion during chronic HIV infection in humanized mice model. She has recently received a fellowship from California HIV/AIDS Research Program.